Anne Y. Warren

Cambridge University Hospitals NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

67h-index27.9kcitations430works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(115), Prostate Cancer Diagnosis and Treatment(110), Renal cell carcinoma treatment(105), Cancer Genomics and Diagnostics(102), Renal and related cancers(64)

Publications380 total

Cribriform-Positive and -Negative Prostate Cancer—Reply
JAMA Oncology·2026
Multiplex Immunofluorescence and Histopathology Dataset of Cell Cycle–Related Proteins in Renal Cell Carcinoma
Data·2026Open Access
Deconvolving metabolic intratumoral heterogeneity in clear cell renal carcinoma with hyperpolarized 13C-pyruvate MRI
2026Open Access
Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarised 13C-MRI and mass spectrometry imaging
Communications Medicine·2026Open Access
Epigenetic Drivers of Localised Prostate Cancers Reveal Neuronal and Microenvironmental Reprogramming and inform Liquid Biopsy Biomarkers
SSRN Electronic Journal·2026· 1 citedOpen Access
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-13 C]pyruvate MRI
Abdominal Radiology·2025Open Access
Histopathology and Lo-multiplex immunofluorescence dataset of cell‐cycle related proteins in renal cell carcinoma – SORCE trial
2025
Supplementary Methods S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Table S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Tables S3-S13 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S3 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Table S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma
Nature Communications·2025Open Access
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer
JAMA Oncology·2025· 6 citedOpen Access
Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility Study
European Urology Oncology·2025· 1 citedOpen Access
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium
The Lancet Oncology·2025· 4 citedOpen Access
36International neoadjuvant kidney cancer consortium guidelines on assessing pathological response after neoadjuvant therapy in kidney cancer
The Oncologist·2025Open Access
10Investigating the mechanisms of neoadjuvant olaparib and cediranib in renal cancer: results of arms 1 to 3 of the WIndow of opportunity in REnal cancer (WIRE) clinical trial
The Oncologist·2025Open Access
page 1 of 19Next →

Frequent Co-authors

David E. Neal(21), Vincent J. Gnanapragasam(18), Hayley C. Whitaker(13), Andy G. Lynch(11), Tristan Barrett(11), Charles Massie(10), Christof Kastner(10), Ian G. Mills(9), Thomas J. Mitchell(8), Rosalind A. Eeles(8), Grant D. Stewart(7), Sam Behjati(7), Michael R. Stratton(7), Alastair Lamb(7), Brendan Koo(7), Ludmil B. Alexandrov(6), David C. Wedge(6), Peter J. Campbell(6), Helen Ross‐Adams(6), Andrew Doble(6)